DR. BIREN G. PATEL M.D. NPI 1205805553

NPI Details

DR. Biren G. Patel, M.D. is an urology in Surprise, AZ with 34 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Biren G. Patel, M.D. NPI is 1205805553. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UN OF CALIFORNIA, IRVINE, COLLEGE OF MEDICINE
Graduation Year:1992

The provider's business location address is:

14674 W MOUNTAIN VIEW BLVD
SUITE 210
SURPRISE, AZ
ZIP 85374-706
Phone: (623) 546-1400
Fax: (623) 546-0745

The NPI 1205805553 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Urinalysis, manual test (HCPCS:81002)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test for gardnerella vaginalis (bacteria), quantification (HCPCS:87512)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Cell examination of urine, manual (HCPCS:88120)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Biopsy of prostate gland (HCPCS:55700)
• Complicated insertion of bladder tube (HCPCS:51703)
• Dilation of bladder and urethra using an endoscope (HCPCS:52341)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies (HCPCS:L8606)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Injection of implant material beneath lining of bladder and/or urethra using an endoscope (HCPCS:51715)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Insertion of tube into ureter using an endoscope through bladder area (HCPCS:52005)
• Insertion of artificial material for pelvic floor defect (HCPCS:57267)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Creation of sling around urethra in female to control leakage (HCPCS:57288)
• Repair of pelvic ligaments through vagina (HCPCS:57282)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Manipulation of stone in ureter using an endoscope (HCPCS:52330)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Destruction and/or removal of large growth of bladder using an endoscope (HCPCS:52240)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 3/17/2006 and was last updated on 2/29/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.